Silo Pharma Inc (SILO)

$0.58 -0.01 (-1.21%)
Market Cap 2.63M
Revenue (ttm) 70,000.00
Net Income (ttm) -4.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,271.43%
Debt to Equity Ratio 0.00
Volume 197,300
Avg Vol 1,133,950
Day's Range N/A - N/A
Shares Out 4.48M
Stochastic %K 36%
Beta 0.01
Analysts Strong Sell
Price Target $10.00

Company Profile

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders....

Industry: Biotechnology
Sector: Healthcare
Phone: 718 400 9031
Address:
677 North Washington Boulevard, Sarasota, United States
Steevotrader
Steevotrader Jun. 17 at 12:21 PM
$SILO they announced to have their patent issued today, while it’s been holding this level with barely any selling, we could see a hell of a move especially with its super low float. Get ready I feel a $1 break is coming Aimo
0 · Reply
aperzy20
aperzy20 Jun. 16 at 11:56 AM
$SILO patent is being issued tomm! maybe we get a pump!
0 · Reply
dogood
dogood Jun. 13 at 7:48 PM
$SILO if she closes now at .70 possible we could $1 above after hrs
0 · Reply
dogood
dogood Jun. 13 at 4:37 PM
$SILO let’s get to .70s
0 · Reply
dogood
dogood Jun. 13 at 9:11 AM
$SILO shall we have news moving to $1 today
1 · Reply
Green_dillo
Green_dillo Jun. 13 at 12:39 AM
$SILO wish i had more.
0 · Reply
boncuk
boncuk Jun. 13 at 12:04 AM
$EPWK $HSDT $SILO
0 · Reply
UltimateSwingTrades
UltimateSwingTrades Jun. 12 at 11:18 PM
$SILO I am accumulating shares on this one Due your dd and make your own call
0 · Reply
dogood
dogood Jun. 12 at 10:25 PM
$SILO come on , get us to $1 plus
0 · Reply
boncuk
boncuk Jun. 12 at 10:20 PM
$SILO
0 · Reply
Latest News on SILO
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Jun 11, 2025, 9:00 AM EDT - 5 days ago

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Jun 5, 2025, 9:15 AM EDT - 11 days ago

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 21, 2025, 8:55 AM EDT - 26 days ago

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

Silo Pharma Announces Closing of $2 Million Public Offering

May 16, 2025, 4:15 PM EDT - 4 weeks ago

Silo Pharma Announces Closing of $2 Million Public Offering

Silo Pharma Announces Pricing of $2 Million Public Offering

May 15, 2025, 9:15 AM EDT - 4 weeks ago

Silo Pharma Announces Pricing of $2 Million Public Offering

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 14, 2025, 4:07 PM EDT - 4 weeks ago

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

May 14, 2025, 8:40 AM EDT - 4 weeks ago

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Apr 30, 2025, 8:11 AM EDT - 6 weeks ago

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Apr 28, 2025, 7:50 AM EDT - 7 weeks ago

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Mar 26, 2025, 8:40 AM EDT - 2 months ago

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Feb 26, 2025, 1:30 PM EST - 3 months ago

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Feb 18, 2025, 8:50 AM EST - 4 months ago

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Feb 11, 2025, 7:45 AM EST - 4 months ago

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Jan 22, 2025, 8:29 AM EST - 5 months ago

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Jan 2, 2025, 8:45 AM EST - 5 months ago

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Dec 18, 2024, 7:35 AM EST - 6 months ago

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Nov 29, 2024, 8:05 AM EST - 7 months ago

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Nov 18, 2024, 8:40 AM EST - 7 months ago

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

Oct 31, 2024, 8:35 AM EDT - 8 months ago

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Sep 10, 2024, 6:35 AM EDT - 10 months ago

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Aug 14, 2024, 2:30 PM EDT - 10 months ago

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Aug 7, 2024, 8:13 AM EDT - 11 months ago

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

Jul 26, 2024, 8:20 AM EDT - 11 months ago

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 22, 2024, 4:45 PM EDT - 11 months ago

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 19, 2024, 8:01 AM EDT - 11 months ago

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug

Jul 18, 2024, 12:44 PM EDT - 11 months ago

Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Jul 18, 2024, 8:25 AM EDT - 11 months ago

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?

Jul 16, 2024, 10:50 AM EDT - 11 months ago

Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?

Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic

Jul 16, 2024, 6:30 AM EDT - 1 year ago

Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic

Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety

Jun 26, 2024, 8:50 AM EDT - 1 year ago

Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety

Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia

Jun 7, 2024, 8:18 AM EDT - 1 year ago

Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia

Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jun 6, 2024, 4:50 PM EDT - 1 year ago

Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety

Jun 4, 2024, 8:41 AM EDT - 1 year ago

Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety

Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention

May 21, 2024, 8:45 AM EDT - 1 year ago

Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention

Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine

May 14, 2024, 8:45 AM EDT - 1 year ago

Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine

Silo Pharma Announces Positive Results for Intranasal PTSD Treatment

Apr 23, 2024, 8:15 AM EDT - 1 year ago

Silo Pharma Announces Positive Results for Intranasal PTSD Treatment

Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer's Disease Therapeutic

Apr 10, 2024, 8:11 AM EDT - 1 year ago

Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer's Disease Therapeutic

Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain

Mar 18, 2024, 7:15 AM EDT - 1 year ago

Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain

Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD

Feb 28, 2024, 8:25 AM EST - 1 year ago

Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD

Silo Pharma's SP-26 Ketamine Implant Demonstrates Successful Drug Delivery

Feb 14, 2024, 8:45 AM EST - 1 year ago

Silo Pharma's SP-26 Ketamine Implant Demonstrates Successful Drug Delivery

Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology

Feb 1, 2024, 10:00 AM EST - 1 year ago

Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology

Silo Pharma Announces Positive Results in Alzheimer's Disease Study

Jan 24, 2024, 8:55 AM EST - 1 year ago

Silo Pharma Announces Positive Results in Alzheimer's Disease Study

Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD

Jan 4, 2024, 8:55 AM EST - 1 year ago

Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD

Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia

Dec 28, 2023, 8:25 AM EST - 1 year ago

Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia

Silo Pharma Enters into Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD

Nov 21, 2023, 8:01 AM EST - 1 year ago

Silo Pharma Enters into Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD

Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD

Nov 8, 2023, 8:11 AM EST - 1 year ago

Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD

Silo Pharma's SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis

Oct 16, 2023, 8:11 AM EDT - 1 year ago

Silo Pharma's SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis

Silo Pharma Initiates Human Factor Study of SPC-15 for the Treatment of PTSD

Oct 11, 2023, 8:35 AM EDT - 1 year ago

Silo Pharma Initiates Human Factor Study of SPC-15 for the Treatment of PTSD

Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA

Sep 20, 2023, 8:28 AM EDT - 1 year ago

Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA

Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD

Sep 12, 2023, 8:50 AM EDT - 1 year ago

Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD

Steevotrader
Steevotrader Jun. 17 at 12:21 PM
$SILO they announced to have their patent issued today, while it’s been holding this level with barely any selling, we could see a hell of a move especially with its super low float. Get ready I feel a $1 break is coming Aimo
0 · Reply
aperzy20
aperzy20 Jun. 16 at 11:56 AM
$SILO patent is being issued tomm! maybe we get a pump!
0 · Reply
dogood
dogood Jun. 13 at 7:48 PM
$SILO if she closes now at .70 possible we could $1 above after hrs
0 · Reply
dogood
dogood Jun. 13 at 4:37 PM
$SILO let’s get to .70s
0 · Reply
dogood
dogood Jun. 13 at 9:11 AM
$SILO shall we have news moving to $1 today
1 · Reply
Green_dillo
Green_dillo Jun. 13 at 12:39 AM
$SILO wish i had more.
0 · Reply
boncuk
boncuk Jun. 13 at 12:04 AM
$EPWK $HSDT $SILO
0 · Reply
UltimateSwingTrades
UltimateSwingTrades Jun. 12 at 11:18 PM
$SILO I am accumulating shares on this one Due your dd and make your own call
0 · Reply
dogood
dogood Jun. 12 at 10:25 PM
$SILO come on , get us to $1 plus
0 · Reply
boncuk
boncuk Jun. 12 at 10:20 PM
$SILO
0 · Reply
aperzy20
aperzy20 Jun. 12 at 6:56 PM
$SILO
0 · Reply
dogood
dogood Jun. 12 at 5:54 PM
$SILO come on guys break .75
0 · Reply
dogood
dogood Jun. 12 at 5:06 PM
$MOVE both should run like after hours $SILO
0 · Reply
Arodrcp
Arodrcp Jun. 12 at 11:44 AM
$SILO On June 17, 2025, Silo’s patent around biomarkers enhancing SPC‑15’s developmental exclusivity will be issued, reinforcing their IP before progressing into Phase 1 trials.
0 · Reply
ladyInRed143
ladyInRed143 Jun. 12 at 9:47 AM
$SILO any good homers here to run this to 1$ 😝
1 · Reply
aperzy20
aperzy20 Jun. 11 at 11:31 PM
$SILO patent is “ to be issued “ on the 17th of June!! That’s blast off day! LFG
0 · Reply
dogood
dogood Jun. 11 at 11:11 PM
$SILO this should have been $2
0 · Reply
ladyInRed143
ladyInRed143 Jun. 11 at 10:21 PM
$SILO this going up tomorrow or is this it
0 · Reply
ScroogeMcquack
ScroogeMcquack Jun. 11 at 6:59 PM
$SILO $DHAI $HCTI $AMZE come get some noon boom 💥 let’s go!
0 · Reply
TaySwift
TaySwift Jun. 11 at 6:37 PM
$SILO WTF news and no movement and recent insider buying wtf i don't get it
0 · Reply
Finanz
Finanz Jun. 11 at 5:38 PM
$SILO Always a bad sign when seemingly good news is me with a collective yawn. Probably due to no credibility assigned to the CEO.
1 · Reply
psm18
psm18 Jun. 11 at 5:25 PM
$SILO shhhhhh ! Nobody reads the news apparently. Get in now before it's discovered (in a whisper voice) Shhhhhh ! 🔥🔥🔥
0 · Reply